CLX vs FDMT · P/E 15, rev $7.10B vs rev $37.0K
The Clorox Company (CLX) versus 4D Molecular Therapeutics Inc (FDMT) — a side-by-side from cached financials, not a winner call.
The Clorox Company (CLX) is a household & personal products company listed on US.
4D Molecular Therapeutics Inc (FDMT) is a biotechnology company listed on US.
Latest reported CLX revenue for 2025-06-30 was $7.10B. Net income was $824.0M. Revenue was up 0.2% from 2024-06-30 to 2025-06-30. CLX currently screens at market cap $10.89B and trailing P/E 14.6.
Latest reported FDMT revenue for 2024-12-31 was $37.0K. Net income was -$160.9M. Revenue was down 99.8% from 2023-12-31 to 2024-12-31. FDMT currently screens at market cap $518.1M.
CLX currently screens at market cap $10.89B and trailing P/E 14.6. FDMT currently screens at market cap $518.1M.
Not investment advice. Open the CLX and FDMT stock pages for the full models.
Not investment advice.